Literature DB >> 17607602

Progressive multifocal leukoencephalopathy in an HIV-infected child.

Z Liptai1, E Papp, P Barsi, I Mihály, E Szalai, J Csomor, Z Jelenik.   

Abstract

Progressive multifocal leukoencephalopathy is an infection of the immunosuppressed, especially of AIDS, patients. The disease is caused by the JC virus and is exceptionally rare in children. The diagnosis is based on MRI and on the detection of JC virus DNA in the cerebrospinal fluid. Progression is relentless in most cases. The only treatment of proven benefit is restoration of the immune system by highly active antiretroviral therapy. We report the case of a 15S-year-old HIV-infected boy. After several months of fatigue he developed apathy, head tilt, diplopia, motor apraxia and unsteady gait. Physical examination revealed mild cerebellar signs. MRI showed a 30-mm large, non-enhancing, hyper-intense area in the right cerebellar hemisphere and the middle cerebellar peduncle. JC virus DNA was detected in the cerebrospinal fluid. Two weeks later the MRI showed progression. The patient's condition rapidly worsened and he died four months after the onset of the disease. Autopsy revealed widespread lesions of the cerebellar hemispheres and the brainstem. The case presented is peculiar owing to the young age of the patient, the unusual localization and the unifocal nature of the lesion.

Entities:  

Mesh:

Year:  2007        PMID: 17607602     DOI: 10.1055/s-2007-981482

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  5 in total

Review 1.  Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review.

Authors:  Hayden Schwenk; Lynn Ramirez-Avila; Shu-Hsien Sheu; Christian Wuthrich; Jeff Waugh; Adam Was; Umberto Degirolami; Sandra Burchett; Igor J Koralnik; Asim Ahmed
Journal:  Pediatr Infect Dis J       Date:  2014-04       Impact factor: 2.129

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

3.  Natalizumab in pediatric multiple sclerosis patients.

Authors:  E Ann Yeh; Bianca Weinstock-Guttman
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

4.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

5.  Progressive Multifocal Leukoencephalopathy in HIV-Infected Children: A Case Report and Literature Review.

Authors:  Peninnah Oberdorfer; Charles H Washington; Kamornwan Katanyuwong; Podjanee Jittamala
Journal:  Int J Pediatr       Date:  2009-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.